Ahead of BTS’ mega-tour blowout – and with their company’s stock price up more than 50% from mid-January 2025 – Hybe execs ...

Debt Management: Stryker's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.76, the ...

As of Tuesday morning, Corcept Therapeutics shares are down by 0.59%, with a current price of $79.35. This implies that Belanoff's 550,000 shares have a value of $41,508,500.

Daniel Nathan and Brian Neil Hoffman of Morrison & Foerster write: Stock option exercises may create additional risks of violating the securities laws depending upon how they are exercised. Through ...

VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Cornish Metals Inc. (CUSN:CA) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its ...

Focused on rare liver disease therapies, this biopharma company reported a significant insider sale amid strong one-year stock gains.

Options give investors the right, but not the obligation, to buy shares with a call or sell them with a put. Deciding whether to exercise or hold an option depends on factors like remaining time value ...

Stock options became common parlance in venture-funded startups in the mid-70s when struggling startups succeeded in attracting the talent and interest of their employees by offering them stock ...